Related Experiment Video
Updated: Jul 3, 2026

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Summary
This study identifies a novel form of adrenoleukodystrophy in siblings with early-onset seizures and neurological decline. The condition, distinct from X-linked adrenoleukodystrophy, presents with adrenal atrophy and white matter degeneration.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Adrenoleukodystrophy (ALD) is a rare genetic disorder affecting the nervous system and adrenal glands.
- The X-linked form of ALD is the most common, typically presenting in childhood or adolescence.
- Understanding novel genetic disorders is crucial for accurate diagnosis and treatment.
Observation:
- Two siblings presented with similar facial features, seizures from birth, and delayed neurological development.
- Deterioration of neurological function began at one year of age, leading to sudden death by age three.
- Clinical signs included skin tanning and adrenal insufficiency (low cortisol response to ACTH).
Findings:
- Autopsy revealed adrenal atrophy and widespread white matter degeneration (leukodystrophy) in both siblings.
- The pattern of inheritance and early onset distinguish this from X-linked ALD.
- Normal computerized axial tomography (CAT) scans in one patient highlight diagnostic challenges.
Implications:
- This suggests a new, likely autosomal, form of adrenoleukodystrophy with a distinct phenotype.
- The findings differentiate it from Zellweger syndrome, emphasizing intrauterine white matter degeneration.
- Further research is needed to elucidate the genetic basis and long-term prognosis of this novel ALD variant.
Related Concept Videos
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

